Beta Bionics, Inc. BBNX Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0000950170-25-064504
cik 1674632
name BETA BIONICS, INC.
sic 3841
countryba US
stprba CA
cityba IRVINE
zipba 92618
bas1 11 HUGHES
bas2
baph 949-427-7785
countryma US
stprma CA
cityma IRVINE
zipma 92618
mas1 11 HUGHES
mas2
countryinc US
stprinc DE
ein 475386878
former BETA BIONICS, INC
changed 20160513
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250506
accepted 2025-05-06 16:20:00.0
prevrpt 0
detail 1
instance bbnx-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0000950170-25-064504 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1357000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Provision For Doubtful Accounts 0.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Accounts Payable Current 3454000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Accounts Receivable Net Current 11996000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Accrued Liabilities And Other Liabilities 10565000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Earnings Per Share Diluted -2.0700 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Additional Paid In Capital 638901000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 2804000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064504 20241231 Assets 0.0000 USD 0 us-gaap/2024 Geographical= Non Us;
0000950170-25-064504 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 12022000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-064504 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20241231 Common Stock Shares Authorized 70000000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20240331 Cost Of Goods And Services Sold 5732000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Deferred Revenue Current 949000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 General And Administrative Expense 3512000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Increase Decrease In Deferred Revenue 480000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Increase Decrease In Operating Lease Liability -224000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Long Term Investments 64004000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Net Cash Provided By Used In Financing Activities 6000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Net Cash Provided By Used In Financing Activities 211119000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Net Cash Provided By Used In Operating Activities -12144000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Operating Income Loss -9453000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240930 Operating Lease Right Of Use Asset 3800000.0000 USD 0 us-gaap/2024 Geographical= C A;
0000950170-25-064504 20250331 Other Assets Noncurrent 146000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Other Nonoperating Income Expense 4000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Other Nonoperating Income Expense 0.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Payments To Acquire Property Plant And Equipment 406000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20241231 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0000950170-25-064504 20241231 Preferred Stock Value USD 0 us-gaap/2024
0000950170-25-064504 20250331 Proceeds From Maturities Prepayments And Calls Of Shortterm Investments 28000000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Proceeds From Stock Options Exercised 98000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Property Plant And Equipment Net 5515000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Research And Development Expense 5479000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Research And Development Expense 7590000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Revenue From Contract With Customer Excluding Assessed Tax 828000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Pharmacy Benefit Plan Channel;
0000950170-25-064504 20250331 Revenue From Contract With Customer Excluding Assessed Tax 4199000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Durable Medical Equipment Channel; Product Or Service= Single Use Products;
0000950170-25-064504 20240331 Share Based Compensation 1357000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20231231 Stockholders Equity 137000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-064504 20240331 Stockholders Equity 40101000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064504 20250331 Stock Issued During Period Shares Stock Options Exercised 14621.0000 shares 1 us-gaap/2024
0000950170-25-064504 20240331 Temporary Equity Carrying Amount Attributable To Parent 261713000.0000 USD 0 us-gaap/2024 Class Of Stock= Convertible Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Carrying Amount Attributable To Parent 78679000.0000 USD 0 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Liquidation Preference 5000000.0000 USD 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Authorized 500000.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Authorized 3960000.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Two Preferred Stock;
0000950170-25-064504 20241130 Temporary Equity Shares Issued 4352393.0000 shares 0 us-gaap/2024 Class Of Stock= Series E Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Issued 4352393.0000 shares 0 us-gaap/2024 Class Of Stock= Series E Preferred Stock;
0000950170-25-064504 20250331 Temporary Equity Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-064504 20250331 Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities -17228954.0000 shares 1 0000950170-25-064504 Class Of Stock= Convertible Preferred Stock;
0000950170-25-064504 20250331 Weighted Average Number Of Diluted Shares Outstanding 30714769.0000 shares 1 us-gaap/2024
0000950170-25-064504 20240331 Weighted Average Number Of Shares Outstanding Basic 6021882.0000 shares 1 us-gaap/2024
0000950170-25-064504 20240331 Accretion Of Discount On Short- Term Investments -875000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20241231 Accrued Liabilities And Other Liabilities 15828000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Adjustments To Additional Paid In Capital Reclassification Of Convertible Preferred Stock And Common Stock Warrants Into Common Stock On Initial Public Offering 57348000.0000 USD 1 0000950170-25-064504 Equity Components= Additional Paid In Capital;
0000950170-25-064504 20241231 Assets Current 132923000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20250331 Common Stock Shares Authorized 0.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20241231 Common Stock Shares Outstanding 2939085.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20250331 Common Stock Value USD 0 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20250331 Comprehensive Income Net Of Tax -28481000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Conversion Of Warrants Net Exercise Upon Initial Public Offering 57348000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20241231 Deferred Costs 5051000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Deferred Revenue Current 939000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Depreciation 303000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Increase Decrease In Accounts Receivable 1918000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Increase Decrease In Other Noncurrent Assets -4000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Investment Income Interest 2436000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20241231 Liabilities Current 21148000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Net Income Loss -12449000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Net Income Loss -28656000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064504 20241231 Operating Lease Liability Noncurrent 5726000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241031 Operating Lease Right Of Use Asset 200000.0000 USD 0 us-gaap/2024 Geographical= C A;
0000950170-25-064504 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax -132000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-064504 20250331 Preferred Stock Shares Authorized 10000000.0000 shares 0 us-gaap/2024
0000950170-25-064504 20250131 Preferred Stock Shares Outstanding 17228954.0000 shares 0 us-gaap/2024 Subsidiary Sale Of Stock= I P O;
0000950170-25-064504 20250331 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0000950170-25-064504 20250331 Preferred Stock Value USD 0 us-gaap/2024
0000950170-25-064504 20240331 Proceeds From Maturities Prepayments And Calls Of Shortterm Investments 8000000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Restricted Cash 100000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Revenue From Contract With Customer Excluding Assessed Tax 291000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Pharmacy Benefit Plan Channel; Product Or Service= I Let;
0000950170-25-064504 20250331 Share Based Compensation 2804000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20231231 Stockholders Equity 1000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20240331 Stockholders Equity 1000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20241231 Stockholders Equity 1000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20250331 Stockholders Equity 638901000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064504 20250331 Stock Issued During Period Value New Issues 190378000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= I P O;
0000950170-25-064504 20250131 Temporary Equity Carrying Amount Attributable To Parent 321400000.0000 USD 0 us-gaap/2024 Subsidiary Sale Of Stock= I P O;
0000950170-25-064504 20241231 Temporary Equity Liquidation Preference 355162000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Temporary Equity Liquidation Preference 60000000.0000 USD 0 us-gaap/2024 Class Of Stock= Series E Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Authorized 500000.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Two Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Authorized 12107140.0000 shares 0 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0000950170-25-064504 20230930 Temporary Equity Shares Issued 6145740.0000 shares 0 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Outstanding 253807.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Outstanding 2130910.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Outstanding 6145740.0000 shares 0 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0000950170-25-064504 20250331 Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities -321373000.0000 USD 1 0000950170-25-064504 Class Of Stock= Convertible Preferred Stock;
0000950170-25-064504 20240331 Weighted Average Number Of Diluted Shares Outstanding 6021882.0000 shares 1 us-gaap/2024
0000950170-25-064504 20240331 Weighted Average Number Of Diluted Shares Outstanding 2989847.0000 shares 1 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20250331 Weighted Average Number Of Diluted Shares Outstanding 0.0000 shares 1 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 2804000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Assets 0.0000 USD 0 us-gaap/2024 Geographical= Non Us;
0000950170-25-064504 20250331 Assets Current 261915000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Capital Expenditures Incurred But Not Yet Paid 5000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Cash And Cash Equivalents At Carrying Value 22072000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 26666000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20250131 Common Stock Shares Issued 1000000.0000 shares 0 us-gaap/2024 Subsidiary Sale Of Stock= Private Placement;
0000950170-25-064504 20250331 Common Stock Shares Issued 0.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20241231 Common Stock Shares Outstanding 3679790.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20241231 Common Stock Shares Outstanding 48918.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20250331 Gross Profit 8971000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Increase Decrease In Inventories 2407000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Net Income Loss -12449000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064504 20250331 Non Cash Unrealized Gain Loss On Short Term Investments 25000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20250331 Operating Expenses 27613000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Operating Lease Right Of Use Asset 6344000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Proceeds From Issuance Of Private Placement 15591000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Revenue From Contract With Customer Excluding Assessed Tax 13827000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Durable Medical Equipment Channel;
0000950170-25-064504 20250331 Revenue From Contract With Customer Excluding Assessed Tax 506000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Pharmacy Benefit Plan Channel; Product Or Service= I Let;
0000950170-25-064504 20231231 Stockholders Equity 26421000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064504 20250331 Stockholders Equity 313752000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Stock Issued During Period Value New Issues 15591000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Private Placement;
0000950170-25-064504 20240331 Stock Issued During Period Value Stock Options Exercised 6000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Stock Issued During Period Value Stock Options Exercised 6000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064504 20250331 Stock Offering Costs 1400000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20241231 Temporary Equity Carrying Amount Attributable To Parent 6589000.0000 USD 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Authorized 8574227.0000 shares 0 us-gaap/2024 Class Of Stock= Series E Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Issued 253807.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Two Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Issued 2082153.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Outstanding 2010144.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Two Preferred Stock;
0000950170-25-064504 20250331 Accretion Of Discount On Short- Term Investments -916000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20250331 Capital Expenditures Incurred But Not Yet Paid 699000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20241231 Common Stock Shares Authorized 0.0000 shares 0 us-gaap/2024
0000950170-25-064504 20241231 Common Stock Shares Authorized 96910.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20241231 Common Stock Shares Issued 2939085.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20250331 Common Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20250331 Cost Of Goods And Services Sold 8668000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Fair Value Adjustment Of Warrants 12450000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 General And Administrative Expense 6621000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Increase Decrease In Accrued Liabilities And Other Operating Liabilities -5273000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Increase Decrease In Operating Lease Liability -281000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20241231 Liabilities 73632000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Net Income Loss -28656000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Non Cash Unrealized Gain Loss On Long Term Investments 150000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20240331 Non Cash Unrealized Gain Loss On Short Term Investments -132000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20250331 Operating Income Loss -18642000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax -132000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Provision For Excess And Obsolete Inventory -23000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20241231 Restricted Cash Noncurrent 100000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Retained Earnings Accumulated Deficit -296737000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Revenue From Contract With Customer Excluding Assessed Tax 9628000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Durable Medical Equipment Channel; Product Or Service= I Let; iLet includes the over-time recognition software updates and mobile app access.
0000950170-25-064504 20241231 Shares Outstanding 6667793.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20250131 Shares Outstanding 6671174.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A Class B And Class C; Subsidiary Sale Of Stock= I P O;
0000950170-25-064504 20241231 Short Term Investments 73143000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Accounts Receivable Net Current 9060000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1357000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064504 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 22172000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 30532000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Common Stock Shares Authorized 0.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20250131 Common Stock Shares Issued 13800000.0000 shares 0 us-gaap/2024 Subsidiary Sale Of Stock= I P O;
0000950170-25-064504 20250331 Common Stock Value 4000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Common Stock Value USD 0 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20250331 Earnings Per Share Basic -0.9300 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Gain Loss On Sale Of Property Plant Equipment -8000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Gross Profit 7201000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Increase Decrease In Inventories 2621000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Liabilities And Stockholders Equity 338024000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Operating Lease Liability Current 1529000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Other Assets Noncurrent 150000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Preferred Stock Shares Authorized 0.0000 shares 0 us-gaap/2024
0000950170-25-064504 20250331 Reclassification Of Deferred Offering Costs To Equity Upon Initial Public Offering 5051000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20250331 Retained Earnings Accumulated Deficit -325393000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Revenue From Contract With Customer Excluding Assessed Tax 1732000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Durable Medical Equipment Channel; Product Or Service= Single Use Products;
0000950170-25-064504 20240331 Shares Outstanding 6022121.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20231231 Stockholders Equity -12317000.0000 USD 0 us-gaap/2024 Cumulative Effect Period Of Adoption= Cumulative Effect Period Of Adoption Adjustment; Equity Components= Retained Earnings;
0000950170-25-064504 20231231 Stockholders Equity -229664000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064504 20240331 Stockholders Equity 5000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-064504 20241231 Stockholders Equity 65000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-064504 20250331 Stock Issued During Period Shares New Issues 1000000.0000 shares 1 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= Private Placement;
0000950170-25-064504 20250331 Stock Issued During Period Shares Stock Options Exercised 14621.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20250331 Stock Issued During Period Value New Issues 15591000.0000 USD 1 us-gaap/2024 Subsidiary Sale Of Stock= Private Placement;
0000950170-25-064504 20250331 Stock Issued During Period Value Stock Options Exercised 98000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064504 20250331 Temporary Equity Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Temporary Equity Shares Authorized 5127250.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0000950170-25-064504 20250331 Temporary Equity Shares Authorized 0.0000 shares 0 us-gaap/2024
0000950170-25-064504 20241231 Temporary Equity Shares Issued 253807.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Issued 2130910.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0000950170-25-064504 20240331 Weighted Average Number Of Diluted Shares Outstanding 48918.0000 shares 1 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20250331 Weighted Average Number Of Diluted Shares Outstanding 0.0000 shares 1 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20250331 Weighted Average Number Of Shares Outstanding Basic 30714769.0000 shares 1 us-gaap/2024
0000950170-25-064504 20241231 Accounts Payable Current 2852000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Additional Paid In Capital 51311000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Assets 149645000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Cash And Cash Equivalents At Carrying Value 42454000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 42554000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-064504 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20250331 Common Stock Shares Authorized 0.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20241231 Common Stock Shares Issued 3679790.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20241231 Common Stock Shares Issued 48918.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20250331 Common Stock Shares Issued 43353890.0000 shares 0 us-gaap/2024
0000950170-25-064504 20250331 Common Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20241231 Common Stock Value 1000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20241231 Common Stock Value USD 0 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20250331 Conversion Of Convertible Preferred Stock Upon Initial Public Offering 321373000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20240331 Depreciation 287000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Fair Value Adjustment Of Warrants 4139000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20241231 Inventory Net 13320000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Investment Income Interest 1139000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Net Cash Provided By Used In Investing Activities -179122000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Nonoperating Income Expense -10014000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Operating Lease Liability Noncurrent 5450000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Payments To Acquire Short Term Investments 142935000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-064504 20241231 Prepaid Expense And Other Assets Current 4032000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Prepaid Expense And Other Assets Current 5652000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Proceeds From Stock Options Exercised 6000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Provision For Doubtful Accounts 17000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Provision For Net Realizable Value Of Inventory 129000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20240331 Revenue From Contract With Customer Excluding Assessed Tax 12933000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Revenue From Contract With Customer Excluding Assessed Tax 12105000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Durable Medical Equipment Channel;
0000950170-25-064504 20250331 Selling And Marketing Expense 13402000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20231231 Stockholders Equity 12317000.0000 USD 0 us-gaap/2024 Cumulative Effect Period Of Adoption= Cumulative Effect Period Of Adoption Adjustment; Equity Components= Additional Paid In Capital;
0000950170-25-064504 20241231 Stockholders Equity -296737000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064504 20250331 Stockholders Equity 4000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20250331 Stock Issued During Period Shares New Issues 12475000.0000 shares 1 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= I P O;
0000950170-25-064504 20250331 Stock Issued During Period Value Conversion Of Convertible Securities 321373000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Stock Issued During Period Value Conversion Of Convertible Securities 321371000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064504 20250331 Stock Issued During Period Value Conversion Of Convertible Securities 2000.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20250331 Stock Issued During Period Value Stock Options Exercised 98000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20231231 Temporary Equity Carrying Amount Attributable To Parent 261713000.0000 USD 0 us-gaap/2024 Class Of Stock= Convertible Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Carrying Amount Attributable To Parent 6626000.0000 USD 0 us-gaap/2024 Class Of Stock= Series A Two Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Liquidation Preference 5000000.0000 USD 0 us-gaap/2024 Class Of Stock= Series A Two Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Liquidation Preference 63053000.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Liquidation Preference 63360000.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Two Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Temporary Equity Shares Outstanding 12876561.0000 shares 0 us-gaap/2024 Class Of Stock= Convertible Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Outstanding 17228954.0000 shares 0 us-gaap/2024
0000950170-25-064504 20241231 Temporary Equity Shares Outstanding 4352393.0000 shares 0 us-gaap/2024 Class Of Stock= Series E Preferred Stock;
0000950170-25-064504 20241231 Warrant Liabilities Noncurrent 44898000.0000 USD 0 0000950170-25-064504
0000950170-25-064504 20250331 Weighted Average Number Of Diluted Shares Outstanding 0.0000 shares 1 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20250331 Provision For Excess And Obsolete Inventory 82000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20250331 Purchases Of Property And Equipment In Accrued Expenses And Other Current Liabilities 10000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax 240000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Adjustments To Additional Paid In Capital Reclassification Of Convertible Preferred Stock And Common Stock Warrants Into Common Stock On Initial Public Offering 57348000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20250331 Adjustments To Additional Paid In Capital Shares Reclassification Of Convertible Preferred Stock And Common Stock Warrants Into Common Stock On Initial Public Offering 3369473.0000 shares 1 0000950170-25-064504 Equity Components= Common Stock;
0000950170-25-064504 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -4494000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20250331 Common Stock Shares Authorized 700000000.0000 shares 0 us-gaap/2024
0000950170-25-064504 20250331 Common Stock Shares Issued 0.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20250331 Common Stock Shares Outstanding 43353890.0000 shares 0 us-gaap/2024
0000950170-25-064504 20241231 Common Stock Value USD 0 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20250331 Deferred Revenue Noncurrent 2330000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Earnings Per Share Basic -2.0700 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Earnings Per Share Diluted -0.9300 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Increase Decrease In Accrued Liabilities And Other Operating Liabilities -231000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Increase Decrease In Deferred Revenue 549000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets 1061000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Operating Lease Right Of Use Asset Amortization Expense 276000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 175000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-064504 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-064504 20250331 Proceeds From Issuance Of Common Stock 195430000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20241231 Property Plant And Equipment Net 4776000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Revenue From Contract With Customer Excluding Assessed Tax 537000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Pharmacy Benefit Plan Channel; Product Or Service= Single Use Products;
0000950170-25-064504 20250331 Revenue From Contract With Customer Excluding Assessed Tax 3812000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Pharmacy Benefit Plan Channel;
0000950170-25-064504 20250331 Revenue From Contract With Customer Excluding Assessed Tax 3306000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Pharmacy Benefit Plan Channel; Product Or Service= Single Use Products;
0000950170-25-064504 20240331 Selling And Marketing Expense 7663000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20231231 Shares Outstanding 6021327.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20250331 Short Term Investments 189019000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Stockholders Equity -254430000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064504 20241231 Stockholders Equity -245360000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Stockholders Equity 240000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-064504 20250331 Stock Issued During Period Value New Issues 1000.0000 USD 1 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= I P O;
0000950170-25-064504 20241231 Temporary Equity Carrying Amount Attributable To Parent 63228000.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Two Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Carrying Amount Attributable To Parent 59660000.0000 USD 0 us-gaap/2024 Class Of Stock= Series E Preferred Stock;
0000950170-25-064504 20250331 Temporary Equity Liquidation Preference 0.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Temporary Equity Shares Authorized 34966547.0000 shares 0 us-gaap/2024
0000950170-25-064504 20241231 Temporary Equity Shares Issued 2010144.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Two Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Issued 6145740.0000 shares 0 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Outstanding 17228954.0000 shares 0 us-gaap/2024 Class Of Stock= Convertible Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Outstanding 2082153.0000 shares 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0000950170-25-064504 20250331 Underwriting Discounts And Commissions And Offering Costs 21700000.0000 USD 1 0000950170-25-064504
0000950170-25-064504 20240331 Weighted Average Number Of Diluted Shares Outstanding 2983117.0000 shares 1 us-gaap/2024 Class Of Stock= Common Class B;
0000950170-25-064504 20231231 Stockholders Equity -203105000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Stock Issued During Period Shares Conversion Of Convertible Securities 19827003.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20240331 Stock Issued During Period Shares Stock Options Exercised 794.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20241231 Temporary Equity Carrying Amount Attributable To Parent 321373000.0000 USD 0 us-gaap/2024 Class Of Stock= Convertible Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Liquidation Preference 57049000.0000 USD 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Authorized 4197930.0000 shares 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Issued 17228954.0000 shares 0 us-gaap/2024
0000950170-25-064504 20231231 Temporary Equity Shares Outstanding 12876561.0000 shares 0 us-gaap/2024 Class Of Stock= Convertible Preferred Stock;
0000950170-25-064504 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax 65000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Assets 338024000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Cash And Cash Equivalents At Carrying Value 30432000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Common Stock Shares Authorized 5790000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0000950170-25-064504 20241231 Common Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-064504 20250331 Common Stock Shares Issued 0.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20241231 Common Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0000950170-25-064504 20250331 Common Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20241231 Common Stock Value USD 0 us-gaap/2024
0000950170-25-064504 20250331 Common Stock Value USD 0 us-gaap/2024 Class Of Stock= Common Class C;
0000950170-25-064504 20240331 Comprehensive Income Net Of Tax -12581000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20241231 Deferred Revenue Noncurrent 1860000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Increase Decrease In Accounts Payable 410000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Increase Decrease In Accounts Payable -97000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Increase Decrease In Accounts Receivable -2936000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Increase Decrease In Other Noncurrent Assets -1000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets 1620000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Inventory Net 15730000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Liabilities 24272000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Liabilities And Stockholders Equity 149645000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Liabilities Current 16492000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Net Cash Provided By Used In Investing Activities 7644000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Net Cash Provided By Used In Operating Activities -19975000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Nonoperating Income Expense -2996000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Operating Expenses 16654000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Operating Lease Liability Current 1524000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Operating Lease Right Of Use Asset 6645000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Operating Lease Right Of Use Asset Amortization Expense 301000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 175000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Payments To Acquire Longterm Investments 63854000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Payments To Acquire Property Plant And Equipment 333000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Proceeds From Sale Of Property Plant And Equipment 50000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20240331 Restricted Cash 100000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20250331 Restricted Cash Noncurrent 100000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20240331 Revenue From Contract With Customer Excluding Assessed Tax 10373000.0000 USD 1 us-gaap/2024 Contract With Customer Sales Channel= Durable Medical Equipment Channel; Product Or Service= I Let;
0000950170-25-064504 20250331 Revenue From Contract With Customer Excluding Assessed Tax 17639000.0000 USD 1 us-gaap/2024
0000950170-25-064504 20250331 Shares Outstanding 43353890.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064504 20240331 Stockholders Equity -214323000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Stockholders Equity 51311000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064504 20250331 Stockholders Equity -325393000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064504 20250331 Stock Issued During Period Value New Issues 190379000.0000 USD 1 us-gaap/2024 Subsidiary Sale Of Stock= I P O;
0000950170-25-064504 20241231 Temporary Equity Carrying Amount Attributable To Parent 321373000.0000 USD 0 us-gaap/2024
0000950170-25-064504 20241231 Temporary Equity Carrying Amount Attributable To Parent 61606000.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Carrying Amount Attributable To Parent 44985000.0000 USD 0 us-gaap/2024 Class Of Stock= Series C Preferred Stock;
0000950170-25-064504 20250131 Temporary Equity Carrying Amount Attributable To Parent 57300000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= I P O;
0000950170-25-064504 20241231 Temporary Equity Liquidation Preference 101700000.0000 USD 0 us-gaap/2024 Class Of Stock= Series D Preferred Stock;
0000950170-25-064504 20241231 Temporary Equity Shares Outstanding 253807.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Two Preferred Stock;
0000950170-25-064504 20250331 Temporary Equity Shares Outstanding 0.0000 shares 0 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Stock Issued During Period Value Stock Options Exercised us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Increase Decrease In Other Noncurrent Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Noncurrent Assets Amount of increase (decrease) in noncurrent assets classified as other.
Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities 0000950170-25-064504 1 0 shares D Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities Temporary equity stock issued during period shares conversion of convertible securities.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Deferred Revenue Current us-gaap/2024 0 0 monetary I C Deferred Revenue, Current Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 0 0 monetary D C OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Proceeds From Stock Options Exercised us-gaap/2024 0 0 monetary D D Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement.
Temporary Equity Shares Issued us-gaap/2024 0 0 shares I Temporary Equity, Shares Issued The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
Proceeds From Issuance Of Private Placement us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Private Placement The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.
Non Cash Unrealized Gain Loss On Short Term Investments 0000950170-25-064504 1 0 monetary D C Non Cash Unrealized Gain (Loss) On Short Term Investments Non cash unrealized gain (loss) on short-term investments.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Short Term Investments us-gaap/2024 0 0 monetary I D Short-Term Investments Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.
Reclassification Of Deferred Offering Costs To Equity Upon Initial Public Offering 0000950170-25-064504 1 0 monetary D C Reclassification Of Deferred Offering Costs To Equity Upon Initial Public Offering Reclassification Of Deferred Offering Costs To Equity Upon Initial Public Offering.
Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities 0000950170-25-064504 1 0 monetary D C Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities Temporary equity stock issued during period value conversion of convertible securities.
Underwriting Discounts And Commissions And Offering Costs 0000950170-25-064504 1 0 monetary D D Underwriting Discounts And Commissions And Offering Costs Underwriting discounts and commissions and offering costs.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Temporary Equity Carrying Amount Attributable To Parent us-gaap/2024 0 0 monetary I C Temporary Equity, Carrying Amount, Attributable to Parent Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Temporary Equity Shares Authorized us-gaap/2024 0 0 shares I Temporary Equity, Shares Authorized The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Accrued Liabilities And Other Liabilities us-gaap/2024 0 0 monetary I C Accrued Liabilities and Other Liabilities Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.
Accretion Of Discount On Short- Term Investments 0000950170-25-064504 1 0 monetary D D Accretion of Discount on Short-Term Investments Accretion of discount on short-term investments.
Provision For Net Realizable Value Of Inventory 0000950170-25-064504 1 0 monetary D D Provision For Net Realizable Value Of Inventory Provision for net realizable value of inventory.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Cost Of Goods And Services Sold us-gaap/2024 0 0 monetary D D Cost of Goods and Services Sold The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Payments To Acquire Longterm Investments us-gaap/2024 0 0 monetary D C Payments to Acquire Long-Term Investments The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.
Selling And Marketing Expense us-gaap/2024 0 0 monetary D D Selling and Marketing Expense The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Conversion Of Warrants Net Exercise Upon Initial Public Offering 0000950170-25-064504 1 0 monetary D C Conversion Of Warrants Net Exercise Upon Initial Public Offering Conversion Of Warrants Net Exercise Upon Initial Public Offering.
Stock Offering Costs 0000950170-25-064504 1 0 monetary D D Stock Offering Costs Stock offering costs.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments us-gaap/2024 0 0 monetary D D Proceeds from Maturities, Prepayments and Calls of Short-Term Investments The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
Warrant Liabilities Noncurrent 0000950170-25-064504 1 0 monetary I C Warrant Liabilities Noncurrent Warrant liabilities noncurrent.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Temporary Equity Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Temporary Equity, Par or Stated Value Per Share Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.
Increase Decrease In Inventories us-gaap/2024 0 0 monetary D C Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Deferred Revenue Noncurrent us-gaap/2024 0 0 monetary I C Deferred Revenue, Noncurrent Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 0 0 monetary D D Proceeds from Sale of Property, Plant, and Equipment The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Conversion Of Convertible Preferred Stock Upon Initial Public Offering 0000950170-25-064504 1 0 monetary D C Conversion Of Convertible Preferred Stock Upon Initial Public Offering Conversion Of Convertible Preferred Stock Upon Initial Public Offering.
Non Cash Unrealized Gain Loss On Long Term Investments 0000950170-25-064504 1 0 monetary D C Non Cash Unrealized Gain Loss On Long Term Investments Non cash unrealized gain loss on long term investments.
Increase Decrease In Accrued Liabilities And Other Operating Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Amount of increase (decrease) in accrued expenses, and obligations classified as other.
Restricted Cash us-gaap/2024 0 0 monetary I D Restricted Cash Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
Long Term Investments us-gaap/2024 0 0 monetary I D Long-Term Investments The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Temporary Equity Shares Outstanding us-gaap/2024 0 0 shares I Temporary Equity, Shares Outstanding The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
Restricted Cash Noncurrent us-gaap/2024 0 0 monetary I D Restricted Cash, Noncurrent Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Adjustments To Additional Paid In Capital Shares Reclassification Of Convertible Preferred Stock And Common Stock Warrants Into Common Stock On Initial Public Offering 0000950170-25-064504 1 0 shares D Adjustments To Additional Paid In Capital, Shares Reclassification Of Convertible Preferred Stock And Common Stock Warrants Into Common Stock On Initial Public Offering Adjustments to additional paid in capital, shares reclassification of convertible preferred stock and common stock warrants into common stock on initial public offering.
Capital Expenditures Incurred But Not Yet Paid us-gaap/2024 0 0 monetary D C Capital Expenditures Incurred but Not yet Paid Future cash outflow to pay for purchases of fixed assets that have occurred.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Inventory Net us-gaap/2024 0 0 monetary I D Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Stock Issued During Period Shares New Issues us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Purchases Of Property And Equipment In Accrued Expenses And Other Current Liabilities 0000950170-25-064504 1 0 monetary D C Purchases Of Property And Equipment In Accrued Expenses And Other Current Liabilities Purchases of property and equipment in accrued expenses and other current liabilities.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Fair Value Adjustment Of Warrants us-gaap/2024 0 0 monetary D D Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability.
Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Property Plant Equipment Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.
Increase Decrease In Operating Lease Liability us-gaap/2024 0 0 monetary D D Increase (Decrease) in Operating Lease Liability Amount of increase (decrease) in obligation for operating lease.
Increase Decrease In Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 0 0 monetary D D Operating Lease, Right-of-Use Asset, Periodic Reduction Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Temporary Equity Liquidation Preference us-gaap/2024 0 0 monetary I C Temporary Equity, Liquidation Preference The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
Adjustments To Additional Paid In Capital Reclassification Of Convertible Preferred Stock And Common Stock Warrants Into Common Stock On Initial Public Offering 0000950170-25-064504 1 0 monetary D C Adjustments to Additional Paid in Capital, Reclassification Of Convertible Preferred Stock And Common Stock Warrants Into Common Stock On Initial Public Offering Adjustments to additional paid in capital, reclassification of convertible preferred stock and common stock warrants into common stock on initial public offering.
Deferred Costs us-gaap/2024 0 0 monetary I D Deferred Costs, Noncurrent Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Depreciation us-gaap/2024 0 0 monetary D D Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Investment Income Interest us-gaap/2024 0 0 monetary D C Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 0 0 shares D Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Proceeds From Issuance Of Common Stock us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Stock Issued During Period Value New Issues us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Payments To Acquire Short Term Investments us-gaap/2024 0 0 monetary D C Payments to Acquire Short-Term Investments The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
Increase Decrease In Deferred Revenue us-gaap/2024 0 0 monetary D D Increase (Decrease) in Deferred Revenue Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Provision For Doubtful Accounts us-gaap/2024 0 0 monetary D D Accounts Receivable, Credit Loss Expense (Reversal) Amount of expense (reversal of expense) for expected credit loss on accounts receivable.
Provision For Excess And Obsolete Inventory 0000950170-25-064504 1 0 monetary D D Provision For Excess and Obsolete Inventory Provision for excess and obsolete inventory.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0000950170-25-064504 2 10 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0000950170-25-064504 2 11 BS 0 H Short Term Investments us-gaap/2024 Short-term investments 0
0000950170-25-064504 2 12 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net 0
0000950170-25-064504 2 13 BS 0 H Inventory Net us-gaap/2024 Inventories, net 0
0000950170-25-064504 2 14 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0000950170-25-064504 2 15 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0000950170-25-064504 2 16 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0000950170-25-064504 2 17 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right-of-use asset 0
0000950170-25-064504 2 18 BS 0 H Restricted Cash Noncurrent us-gaap/2024 Restricted cash 0
0000950170-25-064504 2 19 BS 0 H Deferred Costs us-gaap/2024 Deferred offering costs 0
0000950170-25-064504 2 20 BS 0 H Long Term Investments us-gaap/2024 Long-term investments 0
0000950170-25-064504 2 21 BS 0 H Other Assets Noncurrent us-gaap/2024 Other long-term assets 0
0000950170-25-064504 2 22 BS 0 H Assets us-gaap/2024 Total assets 0
0000950170-25-064504 2 26 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0000950170-25-064504 2 27 BS 0 H Accrued Liabilities And Other Liabilities us-gaap/2024 Accrued expenses and other current liabilities 0
0000950170-25-064504 2 28 BS 0 H Operating Lease Liability Current us-gaap/2024 Operating lease liabilities 0
0000950170-25-064504 2 29 BS 0 H Deferred Revenue Current us-gaap/2024 Deferred revenue 0
0000950170-25-064504 2 30 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0000950170-25-064504 2 31 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease liabilities, net of current portion 0
0000950170-25-064504 2 32 BS 0 H Deferred Revenue Noncurrent us-gaap/2024 Deferred revenue, net of current portion 0
0000950170-25-064504 2 33 BS 0 H Warrant Liabilities Noncurrent 0000950170-25-064504 Warrant liabilities 0
0000950170-25-064504 2 34 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0000950170-25-064504 2 35 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingencies (Note 17) 0
0000950170-25-064504 2 36 BS 0 H Temporary Equity Carrying Amount Attributable To Parent us-gaap/2024 Convertible preferred stock (Series A, A-2, B, B-2, C, D and E), par value of $0.0001 per share; no and 34,966,547 shares authorized at March 31, 2025 and December 31, 2024, respectively; no and 17,228,954 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively; liquidation preference of no and $355,162 at March 31, 2025 and December 31, 2024, respectively 0
0000950170-25-064504 2 38 BS 0 H Common Stock Value us-gaap/2024 Common stock 0
0000950170-25-064504 2 39 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock 0
0000950170-25-064504 2 40 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0000950170-25-064504 2 41 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive income 0
0000950170-25-064504 2 42 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0000950170-25-064504 2 43 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders' equity (deficit) 0
0000950170-25-064504 2 44 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities, convertible preferred stock and stockholders' equity (deficit) 0
0000950170-25-064504 3 8 BS 1 H Temporary Equity Par Or Stated Value Per Share us-gaap/2024 Convertible preferred stock, par value 0
0000950170-25-064504 3 9 BS 1 H Temporary Equity Shares Authorized us-gaap/2024 Convertible preferred stock, shares authorized 0
0000950170-25-064504 3 10 BS 1 H Temporary Equity Shares Issued us-gaap/2024 Convertible preferred stock, shares issued 0
0000950170-25-064504 3 11 BS 1 H Temporary Equity Shares Outstanding us-gaap/2024 Convertible preferred stock, shares outstanding 0
0000950170-25-064504 3 12 BS 1 H Temporary Equity Liquidation Preference us-gaap/2024 Convertible preferred stock, liquidation preference 0
0000950170-25-064504 3 13 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0000950170-25-064504 3 14 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value 0
0000950170-25-064504 3 15 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0000950170-25-064504 3 16 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized 0
0000950170-25-064504 3 17 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred Stock, Shares Issued 0
0000950170-25-064504 3 18 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred Stock, Shares Outstanding 0
0000950170-25-064504 3 19 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0000950170-25-064504 3 20 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0000950170-25-064504 4 1 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Net sales 0
0000950170-25-064504 4 2 IS 0 H Cost Of Goods And Services Sold us-gaap/2024 Cost of sales 0
0000950170-25-064504 4 3 IS 0 H Gross Profit us-gaap/2024 Gross profit 0
0000950170-25-064504 4 5 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0000950170-25-064504 4 6 IS 0 H Selling And Marketing Expense us-gaap/2024 Sales and marketing 0
0000950170-25-064504 4 7 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0000950170-25-064504 4 8 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0000950170-25-064504 4 9 IS 0 H Operating Income Loss us-gaap/2024 Loss from operations 0
0000950170-25-064504 4 11 IS 0 H Investment Income Interest us-gaap/2024 Interest income 0
0000950170-25-064504 4 12 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other income 0
0000950170-25-064504 4 13 IS 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Change in fair value of warrant liabilities 1
0000950170-25-064504 4 14 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other expense, net 0
0000950170-25-064504 4 15 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0000950170-25-064504 4 17 IS 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 Unrealized gain (loss) on short-term investments 0
0000950170-25-064504 4 18 IS 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive loss 0
0000950170-25-064504 4 19 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share attributable to common stockholders, basic 0
0000950170-25-064504 4 20 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share attributable to common stockholders, diluted 0
0000950170-25-064504 4 21 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted-average common shares outstanding, basic 0
0000950170-25-064504 4 22 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted-average common shares outstanding, diluted 0
0000950170-25-064504 5 19 EQ 0 H Temporary Equity Carrying Amount Attributable To Parent us-gaap/2024 Convertible Preferred Stock, beginning balance 0
0000950170-25-064504 5 20 EQ 0 H Temporary Equity Shares Outstanding us-gaap/2024 Convertible Preferred Stock, beginning balance (in shares) 0
0000950170-25-064504 5 21 EQ 0 H Stockholders Equity us-gaap/2024 Beginning balance 0
0000950170-25-064504 5 22 EQ 0 H Shares Outstanding us-gaap/2024 Beginning balance (in shares) 0
0000950170-25-064504 5 23 EQ 0 H Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities 0000950170-25-064504 Conversion of convertible preferred stock into common stock on initial public offering 0
0000950170-25-064504 5 24 EQ 0 H Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities 0000950170-25-064504 Conversion of convertible preferred stock into common stock on initial public offering (in shares) 0
0000950170-25-064504 5 25 EQ 0 H Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 Conversion of convertible preferred stock into common stock on initial public offering 0
0000950170-25-064504 5 26 EQ 0 H Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2024 Conversion of convertible preferred stock into common stock on initial public offering (in shares) 0
0000950170-25-064504 5 27 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Issuance of common stock in offering, net of underwriting discounts and commissions and offering costs 0
0000950170-25-064504 5 28 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Issuance of common stock in offering, net of underwriting discounts and commissions and offering costs (in shares) 0
0000950170-25-064504 5 29 EQ 0 H Adjustments To Additional Paid In Capital Reclassification Of Convertible Preferred Stock And Common Stock Warrants Into Common Stock On Initial Public Offering 0000950170-25-064504 Reclassification of convertible preferred stock and common stock warrants into common stock on initial public offering 0
0000950170-25-064504 5 30 EQ 0 H Adjustments To Additional Paid In Capital Shares Reclassification Of Convertible Preferred Stock And Common Stock Warrants Into Common Stock On Initial Public Offering 0000950170-25-064504 Reclassification of convertible preferred stock and common stock warrants into common stock on initial public offering (in shares) 0
0000950170-25-064504 5 33 EQ 0 H Stock Issued During Period Value Stock Options Exercised us-gaap/2024 Stock option exercises 0
0000950170-25-064504 5 34 EQ 0 H Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 Stock option exercises (in shares) 0
0000950170-25-064504 5 35 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation expense 0
0000950170-25-064504 5 36 EQ 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 Unrealized gain (loss) on short-term investments 0
0000950170-25-064504 5 37 EQ 0 H Net Income Loss us-gaap/2024 Net Income (Loss) 0
0000950170-25-064504 5 38 EQ 0 H Temporary Equity Carrying Amount Attributable To Parent us-gaap/2024 Convertible Preferred Stock, ending balance 0
0000950170-25-064504 5 39 EQ 0 H Temporary Equity Shares Outstanding us-gaap/2024 Convertible Preferred Stock, ending balance (in shares) 0
0000950170-25-064504 5 40 EQ 0 H Stockholders Equity us-gaap/2024 Ending balance 0
0000950170-25-064504 5 41 EQ 0 H Shares Outstanding us-gaap/2024 Ending balance (in shares) 0
0000950170-25-064504 6 7 EQ 1 H Underwriting Discounts And Commissions And Offering Costs 0000950170-25-064504 Underwriting discounts and commissions and offering costs 0
0000950170-25-064504 6 8 EQ 1 H Stock Offering Costs 0000950170-25-064504 Offering costs 0
0000950170-25-064504 7 4 CF 0 H Net Income Loss us-gaap/2024 Net Income (Loss) 0
0000950170-25-064504 7 6 CF 0 H Depreciation us-gaap/2024 Depreciation expense 0
0000950170-25-064504 7 7 CF 0 H Provision For Doubtful Accounts us-gaap/2024 Provision for expected credit losses 0
0000950170-25-064504 7 8 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation expense 0
0000950170-25-064504 7 9 CF 0 H Provision For Excess And Obsolete Inventory 0000950170-25-064504 Provision for excess and obsolete inventory 0
0000950170-25-064504 7 10 CF 0 H Provision For Net Realizable Value Of Inventory 0000950170-25-064504 Provision for net realizable value of inventory 0
0000950170-25-064504 7 11 CF 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Change in fair value of warrant liabilities 0
0000950170-25-064504 7 12 CF 0 H Accretion Of Discount On Short- Term Investments 0000950170-25-064504 Accretion of discount on short-term investments 0
0000950170-25-064504 7 13 CF 0 H Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 Amortization of operating lease right-of-use asset 0
0000950170-25-064504 7 14 CF 0 H Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 Loss on disposal of property and equipment 1
0000950170-25-064504 7 16 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts receivable 1
0000950170-25-064504 7 17 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories 1
0000950170-25-064504 7 18 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0000950170-25-064504 7 19 CF 0 H Increase Decrease In Other Noncurrent Assets us-gaap/2024 Other long-term assets 1
0000950170-25-064504 7 20 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable 0
0000950170-25-064504 7 21 CF 0 H Increase Decrease In Accrued Liabilities And Other Operating Liabilities us-gaap/2024 Accrued expenses and other current liabilities 0
0000950170-25-064504 7 22 CF 0 H Increase Decrease In Operating Lease Liability us-gaap/2024 Operating lease liability 0
0000950170-25-064504 7 23 CF 0 H Increase Decrease In Deferred Revenue us-gaap/2024 Deferred revenue 0
0000950170-25-064504 7 24 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0000950170-25-064504 7 26 CF 0 H Payments To Acquire Short Term Investments us-gaap/2024 Purchases of short-term investments 1
0000950170-25-064504 7 27 CF 0 H Payments To Acquire Longterm Investments us-gaap/2024 Purchases of long-term investments 1
0000950170-25-064504 7 28 CF 0 H Proceeds From Maturities Prepayments And Calls Of Shortterm Investments us-gaap/2024 Proceeds from maturities and redemptions of short-term investments 0
0000950170-25-064504 7 29 CF 0 H Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 Proceeds on disposal of property and equipment 0
0000950170-25-064504 7 30 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchases of property and equipment 1
0000950170-25-064504 7 31 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash (used in) provided by investing activities 0
0000950170-25-064504 7 33 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Proceeds from the issuance of common stock, net of underwriting discounts, commissions and issuance costs 0
0000950170-25-064504 7 34 CF 0 H Proceeds From Issuance Of Private Placement us-gaap/2024 Proceeds from the issuance of common stock from private placement, net of issuance costs 0
0000950170-25-064504 7 35 CF 0 H Proceeds From Stock Options Exercised us-gaap/2024 Proceeds from stock option exercises 0
0000950170-25-064504 7 36 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0000950170-25-064504 7 37 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net increase (decrease) in cash, cash equivalents and restricted cash 0
0000950170-25-064504 7 38 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash at beginning of period 0
0000950170-25-064504 7 39 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash at end of period 0
0000950170-25-064504 7 41 CF 0 H Capital Expenditures Incurred But Not Yet Paid us-gaap/2024 Purchases of property and equipment included in accounts payable 0
0000950170-25-064504 7 42 CF 0 H Purchases Of Property And Equipment In Accrued Expenses And Other Current Liabilities 0000950170-25-064504 Purchases of property and equipment in accrued expenses and other current liabilities 0
0000950170-25-064504 7 43 CF 0 H Non Cash Unrealized Gain Loss On Short Term Investments 0000950170-25-064504 Unrealized gain (loss) on short-term investments 0
0000950170-25-064504 7 44 CF 0 H Non Cash Unrealized Gain Loss On Long Term Investments 0000950170-25-064504 Unrealized gain on long-term investments 0
0000950170-25-064504 7 45 CF 0 H Conversion Of Convertible Preferred Stock Upon Initial Public Offering 0000950170-25-064504 Conversion of convertible preferred stock upon IPO 0
0000950170-25-064504 7 46 CF 0 H Conversion Of Warrants Net Exercise Upon Initial Public Offering 0000950170-25-064504 Conversion of warrants net exercise upon IPO 0
0000950170-25-064504 7 47 CF 0 H Reclassification Of Deferred Offering Costs To Equity Upon Initial Public Offering 0000950170-25-064504 Reclassification of deferred offering costs to equity upon IPO 0
0000950170-25-064504 7 49 CF 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0000950170-25-064504 7 50 CF 0 H Restricted Cash us-gaap/2024 Restricted cash 0
0000950170-25-064504 7 51 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Total cash, cash equivalents and restricted cash shown in the statement of cash flows 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.